Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Fentanyl Vaccine
2025-524277-16-00Phase 2Authorised
- Sponsor
- ARMR Sciences
- Start
- Feb 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fentanyl vaccine in hypopnea, sponsored by ARMR Sciences. Planned start Feb 2026; status: authorised.
02
Drugs
fentanyl vaccine
03
Conditions
hypopnea
Beyond the preview
Go deeper on 2025-524277-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524277-16-00.